Acute myeloid leukaemia
- PMID: 17126723
- DOI: 10.1016/S0140-6736(06)69780-8
Acute myeloid leukaemia
Abstract
Acute myeloid leukaemia (AML) is a heterogeneous clonal disorder of haemopoietic progenitor cells and the most common malignant myeloid disorder in adults. The median age at presentation for patients with AML is 70 years. In the past few years, research in molecular biology has been instrumental in deciphering the pathogenesis of the disease. Genetic defects are thought to be the most important factors in determining the response to chemotherapy and outcome. Whereas significant progress has been made in the treatment of younger adults, the prospects for elderly patients have remained dismal, with median survival times of only a few months. This difference is related to comorbidities associated with ageing and to disease biology. Current efforts in clinical research focus on the assessment of targeted therapies. Such new approaches will probably lead to an increase in the cure rate.
Comment in
-
Acute myeloid leukaemia.Lancet. 2007 Feb 3;369(9559):367. doi: 10.1016/S0140-6736(07)60183-4. Lancet. 2007. PMID: 17276770 No abstract available.
Similar articles
-
A systematic overview of chemotherapy effects in acute myeloid leukaemia.Acta Oncol. 2001;40(2-3):231-52. doi: 10.1080/02841860151116321. Acta Oncol. 2001. PMID: 11441935 Review.
-
Acute myeloid leukemia in elderly patients: experience of a single center.Braz J Med Biol Res. 2003 Jun;36(6):703-8. doi: 10.1590/s0100-879x2003000600004. Epub 2003 Jun 3. Braz J Med Biol Res. 2003. PMID: 12792698
-
Patients with de novo acute myeloid leukaemia and complex karyotype aberrations show a poor prognosis despite intensive treatment: a study of 90 patients.Br J Haematol. 2001 Jan;112(1):118-26. doi: 10.1046/j.1365-2141.2001.02511.x. Br J Haematol. 2001. PMID: 11167792 Clinical Trial.
-
Frequency and clinical significance of the expression of the multidrug resistance proteins MDR1/P-glycoprotein, MRP1, and LRP in acute myeloid leukemia: a Southwest Oncology Group Study.Blood. 1999 Aug 1;94(3):1086-99. Blood. 1999. PMID: 10419902 Clinical Trial.
-
Prospects for cure in leukaemia.J Clin Pathol. 1987 Sep;40(9):985-94. doi: 10.1136/jcp.40.9.985. J Clin Pathol. 1987. PMID: 3312307 Free PMC article. Review.
Cited by
-
Immunophenotype Discovery, Hierarchical Organization, and Template-Based Classification of Flow Cytometry Samples.Front Oncol. 2016 Aug 31;6:188. doi: 10.3389/fonc.2016.00188. eCollection 2016. Front Oncol. 2016. PMID: 27630823 Free PMC article.
-
Functionally distinct roles for different miR-155 expression levels through contrasting effects on gene expression, in acute myeloid leukaemia.Leukemia. 2017 Apr;31(4):808-820. doi: 10.1038/leu.2016.279. Epub 2016 Oct 14. Leukemia. 2017. PMID: 27740637
-
Anti-TIM3 chimeric antigen receptor-natural killer cells from engineered induced pluripotent stem cells effectively target acute myeloid leukemia cells.Cancer Cell Int. 2023 Nov 27;23(1):297. doi: 10.1186/s12935-023-03153-9. Cancer Cell Int. 2023. PMID: 38012684 Free PMC article.
-
Granulocyte-Macrophage-Colony-Stimulating-Factor Combined with Prostaglandin E1 Create Dendritic Cells of Leukemic Origin from AML Patients' Whole Blood and Whole Bone Marrow That Mediate Antileukemic Processes after Mixed Lymphocyte Culture.Int J Mol Sci. 2023 Dec 13;24(24):17436. doi: 10.3390/ijms242417436. Int J Mol Sci. 2023. PMID: 38139264 Free PMC article.
-
Ordering of mutations in acute myeloid leukemia with partial tandem duplication of MLL (MLL-PTD).Leukemia. 2017 Jan;31(1):1-10. doi: 10.1038/leu.2016.160. Epub 2016 Jun 8. Leukemia. 2017. PMID: 27389053 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous
